LOX Gene: Lysyl Oxidase - Function, Disease Associations, and Clinical Significance

Comprehensive biomedical overview of the LOX gene, encoding lysyl oxidase, a key enzyme in extracellular matrix remodeling, with implications in fibrosis, cancer, and connective tissue disorders.

Gene Information Card

Symbol LOX
Full Name Lysyl Oxidase
Gene Type Protein coding
Chromosomal Location 5q23.1
NCBI Gene ID 4015 ncbi.nlm.nih.gov/gene/4015
Ensembl ID ENSG00000113083
UniProt ID P28300
OMIM ID 153455
HGNC ID 6664
Aliases Lysyl oxidase; Protein-lysine 6-oxidase; LOX; MGC105117

Description

The LOX gene encodes lysyl oxidase, a copper-dependent amine oxidase that catalyzes the crosslinking of collagen and elastin in the extracellular matrix (ECM). This enzymatic activity is critical for the structural integrity and tensile strength of connective tissues. LOX is synthesized as a 50 kDa proenzyme (pro-LOX) and secreted into the ECM, where it is proteolytically cleaved by bone morphogenetic protein 1 (BMP1) into a functional 32 kDa enzyme and an 18 kDa propeptide (LOX-PP). The active enzyme initiates the formation of covalent crosslinks by oxidizing peptidyl lysine and hydroxylysine residues in collagen, and lysine residues in elastin, to peptidyl alpha-aminoadipic-delta-semialdehyde (allysine). Beyond its structural role, LOX and its propeptide have been implicated in various cellular processes, including cell motility, gene regulation, and tumor suppression or promotion, depending on the cellular context. Dysregulation of LOX expression and activity is associated with fibrotic diseases, cardiovascular disorders, and cancer progression.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Thoracic Aortic Aneurysm and Dissection Loss-of-function mutations in LOX impair collagen and elastin crosslinking in the aortic wall, leading to weakened structural integrity, progressive dilation, and risk of dissection. OMIM: 617168; PubMed: 27105876
Cutis Laxa, Autosomal Recessive, Type 1C Homozygous or compound heterozygous mutations in LOX result in defective elastin crosslinking, causing loose, sagging skin and other connective tissue abnormalities. OMIM: 613177; PubMed: 27105876
Cancer (Various, e.g., Breast, Colon, Head and Neck) LOX is often overexpressed in solid tumors and is associated with hypoxia-induced metastasis. It promotes tumor cell invasion, migration, and pre-metastatic niche formation by remodeling the ECM and activating signaling pathways like FAK and PI3K/AKT. COSMIC; PubMed: 27105876; PubMed: 21746814
Fibrosis (Pulmonary, Hepatic, Renal) Elevated LOX expression and activity drive excessive collagen crosslinking and deposition, leading to tissue scarring and organ dysfunction in fibrotic diseases. PubMed: 21746814; PubMed: 27105876

Expression Profile

Tissue Expression
Tissue nTPM level
Heart 9.6 Low
Lung 12.3 Low
Liver 8.1 Low
Kidney 10.5 Low
Adipose Tissue 14.2 Medium
Skin 18.7 Medium
Aorta 25.4 High
Uterus 16.9 Medium
Placenta 13.8 Medium
Spleen 6.2 Low
Cell Line Expression
Cell Line nTPM Notes
A549 (Lung Carcinoma) 15.3 Moderate expression; associated with invasive phenotype
MCF7 (Breast Adenocarcinoma) 8.7 Low expression; increased under hypoxic conditions
HepG2 (Hepatocellular Carcinoma) 7.9 Low expression
HUVEC (Endothelial) 12.1 Moderate expression; involved in vascular remodeling
BJ (Fibroblast) 22.5 High expression; key role in ECM production
U2OS (Osteosarcoma) 11.4 Moderate expression; linked to bone matrix formation
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.694G>A (p.Gly232Arg) Missense Rare (found in familial TAAD) Loss of function; disrupts copper binding and catalytic activity, impairing crosslinking.
c.829C>T (p.Arg277Cys) Missense Rare (found in familial TAAD) Loss of function; affects protein stability and secretion, leading to reduced enzyme activity.
c.1003C>T (p.Arg335Ter) Nonsense Rare (found in cutis laxa) Loss of function; premature truncation, likely leading to nonsense-mediated decay and absence of functional protein.
c.1123G>A (p.Gly375Ser) Missense Rare (found in cutis laxa) Loss of function; disrupts the active site, reducing catalytic efficiency.
c.1186C>T (p.Arg396Trp) Missense Rare (found in TAAD) Loss of function; affects substrate binding and enzyme activity.
Mutation functional classification

Loss of Function (LOF)

The majority of disease-associated LOX mutations are loss-of-function. These mutations impair the enzyme's catalytic activity, its secretion, or its stability, leading to reduced collagen and elastin crosslinking. This results in weakened connective tissues, as seen in thoracic aortic aneurysm and cutis laxa. In cancer, however, loss of LOX function in the tumor stroma can paradoxically promote tumor progression in some contexts.

Gain of Function (GOF)

Gain-of-function mutations in LOX are not commonly reported in germline disorders. However, somatic copy number gains and transcriptional upregulation (not necessarily mutations) leading to increased LOX expression are frequently observed in various cancers, contributing to metastasis and fibrosis. These are considered functional gains at the expression level rather than activating mutations.

Dominant Negative (DN)

Some missense mutations in LOX may exert a dominant-negative effect. For instance, a mutant LOX monomer could dimerize with a wild-type monomer, resulting in a non-functional heterodimer that is secreted and interferes with normal crosslinking. This mechanism has been proposed for certain TAAD-associated mutations, although haploinsufficiency is also a plausible mechanism.

Gene Ontology (GO)

• Protein-lysine 6-oxidase activity • Copper ion binding
• Extracellular matrix structural constituent • Oxidoreductase activity
• Scavenger receptor activity • Extracellular region
• Extracellular matrix • Collagen fibril organization
• Elastin metabolic process • Cellular response to hypoxia
• Cell adhesion • Angiogenesis
• Response to oxidative stress

Pathways

Collagen biosynthesis and modifying enzymes
Elastin synthesis
Extracellular matrix organization
Integrin signaling pathway
Hypoxia-inducible factor (HIF) signaling
TGF-beta signaling pathway
Focal adhesion pathway

Protein Summary

Lysyl oxidase (LOX) is a 417-amino acid, copper-dependent amine oxidase. It is synthesized as a preproprotein with a signal peptide, a propeptide region (LOX-PP), and a conserved catalytic domain at the C-terminus. The catalytic domain contains the copper-binding site, the lysyl tyrosyl quinone (LTQ) cofactor, and the cytokine receptor-like (CRL) domain. The propeptide is cleaved extracellularly by BMP1 to yield the active enzyme. The active LOX enzyme deaminates lysine and hydroxylysine residues in collagen and elastin, producing allysine, which spontaneously reacts to form crosslinks. LOX-PP, the released propeptide, has its own biological activities, including tumor suppressor functions and regulation of cell differentiation. LOX is secreted and localizes to the ECM, where it plays a structural role. It is also found intracellularly, where it can influence gene transcription. The protein is highly conserved across species.

Related Products

Product name Cat.No. Species Gene ID
LOX Knockout HEK293 Cell Line EDJ-KQ3160 Human 4015 Details Get a Quote
ALOX15B Knockout HEK293 Cell Line EDJ-KQ3377 Human 247 Details Get a Quote
ALOX5 Knockout HEK293 Cell Line EDC07829 Human 240 Details Get a Quote
ALOX12 Knockout HEK293 Cell Line EDJ-KQ4042 Human 239 Details Get a Quote
ALOX12B Knockout HEK293 Cell Line EDC07792 Human 242 Details Get a Quote
ALOX15 Knockout HEK293 Cell Line EDJ-KQ4044 Human 246 Details Get a Quote
ALOX5AP Knockout HEK293 Cell Line EDC07759 Human 241 Details Get a Quote
LOXL1 Knockout HEK293 Cell Line EDJ-KQ5137 Human 4016 Details Get a Quote
LOXHD1 Knockout HEK293 Cell Line EDJ-KQ8786 Human 125336 Details Get a Quote
LOXL4 Knockout HEK293 Cell Line EDJ-KQ10000 Human 84171 Details Get a Quote
LOXL3 Knockout HEK293 Cell Line EDJ-KQ10168 Human 84695 Details Get a Quote
ALOXE3 Knockout HEK293 Cell Line EDC07790 Human 59344 Details Get a Quote
LOXL2 Knockout HEK293 Cell Line EDJ-KQ17787 Human 4017 Details Get a Quote
LOXL1 Knockout HCT 116 Cell Line EDJ-KQ28100 Human 4016 Details Get a Quote
LOXL1 Knockout HeLa Cell Line EDJ-KQ28101 Human 4016 Details Get a Quote
Displaying Records 1 To 15 Of 59 Records
Contact Us
*
*
*
*
How did you hear about us: